Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
STOK.OQ - Stoke Therapeutics Inc
Stoke Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 07:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, welcome once again to the 46th annual TD cow and Health Care conference. I'm Yon Werber, from the Biotech team, and it's a great pleasure to moderate the next fireside chat with Stoke Therapeutics. To my right needs no introduction, Ian Smith, CEO, and to his right, Jason Hoyt, Chief Patient Officer who joined the company about 2 years ago. Ago. Excellent.
Thank you, and I think you did the panel with us last year too. I did fantastic. And Ian, I think it's our first fireside chat on, in capacity of Stoke.
So, really a lot to talk about, in terms of FDA interactions, enrollment, long-term follow-up from the phase 12, and ultimately how that can play into the label, enrollment in the phase 3.
Trustpilot
